Intrexon | XON - سود عملیاتی





سود عملیاتی تغییر دادن تاریخ
Agenus USD 14.4M 19.26M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
MacroGenics USD -12.1M 30.74M 2025-12
MannKind USD -69.24M 28.19M 2025-12
Merck USD 6.24B 318M 2025-12
Novartis USD 4.06B 437M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Xencor USD -53.63M 6.11M 2025-12